Nick Davis MD & Associates

Nick Davis, MD, and Associates is located in Miamisburg Ohio. In a city known for its large health systems, we are proud to be breaking the mold! Our concierge membership model allows us to offer patients better care. Compared to a traditional practice, we see less patients each day and spend more time together building relationships. We offer comprehensive, evidence-based, primary care for men, women, and children. You deserve better access to your healthcare whether that be appointment times, speaking directly with your doctor, or help navigating your unique needs. Let us give you the healthcare you deserve!

Testing Process

Step One:

Book an appointment.

We are thankful to be a part of your unique health journey! Take the first steps in assessing your cancer risk today and schedule with a Ms.Medicine provider now.

If you are already enrolled as a member within a Ms.Medicine practice, your membership includes your consultation with your physician and the charge listed is for the test itself.

If you are not a member at this time but are interested in the Galleri Testing, you are required to have a 45-minute pre-testing consult with the physician, to ensure the appropriateness of the test, as well as a post-testing consult to review results. If you are interested in becoming a member prior to testing, visit mymsmedicine.com and enroll today.

Step Two:

Complete your blood draw.

Thinking about the possibility of cancer is overwhelming but taking the steps to find cancer early can help you feel more in control. Testing is fast and easy; no fasting or advanced preparation is needed. The blood draw can be completed in under 15 minutes.

Step 3: Receive your results and next steps.

Next steps:

Continue with all routine screening tests recommended for you. Missing routine cancer screenings or ignoring symptoms could lead to a delayed diagnosis of cancer.
Next steps:

The Galleri test does not diagnose cancer. Appropriate follow-up testing will be discussed to confirm if cancer is present.

Breakthrough Test Performance

SENSITIVITY

This means that the Galleri test reported a “Cancer Signal Detected” result in approximately 52 individuals out of 100 who actually had cancer.
SPECIFICITY

This means that the Galleri test reported a “Cancer Signal Not Detected” result in approximately 99 individuals out of 100 who do not actually have cancer.
FALSE POSITIVE RATE

This means that the Galleri test reported a “Cancer Signal Detected” result 1 in every 200 tests run in individuals who did NOT actually have cancer.
CANCER SIGNAL ORIGIN ACCURACY

This means when a cancer signal was detected in an individual who actually had cancer, the first Cancer Signal Origin was correctly predicted in 89 of 100 times.